药物诱导的结石:使用FDA不良事件报告系统数据库的现实世界药监测研究
Pan Ding1, Qinghua Luo1, Leihua Cao1
1Department of urology, Nanchang People's Hospital, Nanchang, China.
Frontiers in pharmacology
|April 11, 2025
概括
这项研究使用FDA不良事件报告系统 (FAERS) 数据识别了与结石相关的药物. 许多药物,包括兰索普拉和特杜格卢,显示了新出现的结石风险,这些风险在药物标签上没有列出.
科学领域:
- 药物监督 药物监督 药物监督
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药品安全 药品安全
背景情况:
- 结石 (结石) 是一个重要的健康问题.
- 识别与药物相关的风险对于患者安全和临床实践至关重要.
研究的目的:
- 为了确定最常与结石相关的不良事件相关的药物.
- 为药物使用和潜在的结石风险提供临床见解.
主要方法:
- 利用了FDA不良事件报告系统 (FAERS) 从2004年第一季度到2024年第一季度的数据.
- 使用MedDRA术语"石病"确定了石事件.
- 使用报告几率比率 (ROR) 量化风险信号,与药物标签相比.
主要成果:
- 在21,035,995个不良事件中报告了38,307起石事件.
- 与结石相关的最重要的药物:阿达利穆马布,因弗利克西马布,干扰素β-1a,氧酸盐,特里巴拉提德.
- 确定了兰索普拉,Xywav和泰杜格胺的重大新风险信号;33种药物之前缺乏石标签.
结论:
- 根据FAERS的数据,33种药物出现了新的结石风险信号.
- 建议对这些药物进行密切监测.
- 需要进一步的研究来了解药物诱导的结石形成机制.
相关概念视频
Pharmacovigilance
750
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
750
Renal Failure: Dose Adjustments
37
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
37
Drug Regulation
1.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.2K
Kidney Structure
67.0K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
67.0K
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
145
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
145
Renal Drug Excretion: Tubular Secretion
94
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
94


